{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:00:19Z","timestamp":1791219619391,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T00:00:00Z","timestamp":1270684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T00:00:00Z","timestamp":1270684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/leu.2010.55","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T05:44:50Z","timestamp":1270705490000},"page":"1099-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells"],"prefix":"10.1038","volume":"24","author":[{"given":"A","family":"Puissant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dufies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Cassuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Auberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,8]]},"reference":[{"key":"BFleu201055_CR1","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc1738","volume":"5","author":"G Kroemer","year":"2005","unstructured":"Kroemer G, Jaattela M . Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886\u2013897.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201055_CR2","doi-asserted-by":"publisher","first-page":"19140","DOI":"10.1074\/jbc.M802513200","volume":"283","author":"G Droga-Mazovec","year":"2008","unstructured":"Droga-Mazovec G, Bojic L, Petelin A, Ivanova S, Romih R, Repnik U et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 2008; 283: 19140\u201319150.","journal-title":"J Biol Chem"},{"key":"BFleu201055_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1084\/jem.20021952","volume":"197","author":"P Boya","year":"2003","unstructured":"Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003; 197: 1323\u20131334.","journal-title":"J Exp Med"},{"key":"BFleu201055_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/leu.2009.233","volume":"24","author":"A Puissant","year":"2010","unstructured":"Puissant A, Colosetti P, Robert G, Cassuto JP, Raynaud S, Auberger P . Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells. Leukemia 2010; 24: 115\u2013124.","journal-title":"Leukemia"},{"key":"BFleu201055_CR5","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/sj.onc.1210034","volume":"26","author":"A Jacquel","year":"2007","unstructured":"Jacquel A, Colosetti P, Grosso S, Belhacene N, Puissant A, Marchetti S et al. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. Oncogene 2007; 26: 2445\u20132458.","journal-title":"Oncogene"},{"key":"BFleu201055_CR6","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.148.12.3950","volume":"148","author":"DL Thiele","year":"1992","unstructured":"Thiele DL, Lipsky PE . Apoptosis is induced in cells with cytolytic potential by L-leucyl-L-leucine methyl ester. J Immunol 1992; 148: 3950\u20133957.","journal-title":"J Immunol"},{"key":"BFleu201055_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1073\/pnas.0408592102","volume":"102","author":"H Erdal","year":"2005","unstructured":"Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S . Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 2005; 102: 192\u2013197.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201055_CR8","first-page":"2143","volume":"119","author":"A Ivanov","year":"2009","unstructured":"Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J Clin Invest 2009; 119: 2143\u20132159.","journal-title":"J Clin Invest"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201055","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T14:59:37Z","timestamp":1685545177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,8]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BFleu201055"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.55","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,8]]},"assertion":[{"value":"8 April 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}